StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aristotle will never be release and is already OBSOLETE!

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Mar 22, 2021 2:51pm

91 Views

Post# 32851563

RE:RE:Aristotle will never be release and is already OBSOLETE!

LithLover wrote: No one is selling. Buy at this level or don't Go away fly

IYRPVFV wrote: Watch and learn

I can`t imagine how anyone could consider selling when the company`s biggest NR ever is about to be released. This has been18 years in the making and first to market in the liquid biopsy sphere - with the right marketing package and affiliations, this has the pportunity to meet Clarus and Tripp`s prediction status of a multi billion dollar company. We have all seen Exas`rise with an argueably weaker product so yes, the potential is there. Excitng times ahead!